Biomedical researchers would like to be able to deliver chemicals directly to a cell nucleus-cancer therapy being one reason. UCLA chemist Fred Hawthorne may have discovered a chemical “roach motel” that provides entry to but no exit from the nucleus. He found the passageway while trying to get boron-rich compounds into cells in studies of a cancer treatment called boron neutron capture therapy (BNCT). In BNCT, boron atoms interact with neutron beams to create an unstable isotope that blows apart, as if the neutron had tripped a landmine inside the cell.
Hawthorne has designed novel, small molecules called nido-carboranyl oligomeric phosphate diesters-nido-OPDs-that carry boron into cell interiors more effectively than before. Although Hawthorne expected that the small nido-OPDs molecules would diffuse in and out of the nucleus, he found that they accumulated; once the molecules checked in, they didn’t check out. Most were still present in the nucleus 24 hours later, a finding that could help make BNCT a much more effective cancer treatment in the future.
DeepMind’s cofounder: Generative AI is just a phase. What’s next is interactive AI.
“This is a profound moment in the history of technology,” says Mustafa Suleyman.
What to know about this autumn’s covid vaccines
New variants will pose a challenge, but early signs suggest the shots will still boost antibody responses.
Human-plus-AI solutions mitigate security threats
With the right human oversight, emerging technologies like artificial intelligence can help keep business and customer data secure
Next slide, please: A brief history of the corporate presentation
From million-dollar slide shows to Steve Jobs’s introduction of the iPhone, a bit of show business never hurt plain old business.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.